⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HUMA News
Humacyte, Inc. Common Stock
Humacyte To Announce 2025 Fourth Quarter and Year End Financial Results and Provide Business Update on March 27, 2026
globenewswire.com
HUMA
Form 8-K
sec.gov
HUMA
HUMAW
Humacyte Receives Symvess® Purchase Commitment for Clinical Evaluation and Outreach Program in the Kingdom of Saudi Arabia
globenewswire.com
HUMA
Humacyte, Inc. Announces Pricing of $20 Million Registered Direct Offering of Common Stock
globenewswire.com
HUMA
Form 8-K
sec.gov
HUMA
HUMAW
Humacyte Submits Marketing Authorization Application for Symvess® in Israel for Vascular Trauma Repair
globenewswire.com
HUMA
Humacyte To Participate in Upcoming Investor Conferences
globenewswire.com
HUMA
Humacyte Announces Presentation of Symvess® Long-Term Safety and Efficacy Results at VESS Meeting
globenewswire.com
HUMA
Humacyte Announces New U.S. Department of Defense Funding for Procurement of Bioengineered Blood Vessels
globenewswire.com
HUMA
HUMAIN e Infra anuncian Acuerdo Marco de Financiamiento Estratégico para IA e Infraestructura Digital
businesswire.com
HUMA